{"version":"1.0","provider_name":"Tafalgie Therapeutics","provider_url":"https:\/\/tafalgie.fr\/fr\/","author_name":"Tafalgie_client_23","author_url":"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/","title":"Premier communiqu\u00e9 de presse - Tafalgie Therapeutics","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"g39YGOytOR\"><a href=\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/\">Premier communiqu\u00e9 de presse<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/tafalgie.fr\/fr\/premier-communique-de-presse\/embed\/#?secret=g39YGOytOR\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Premier communiqu\u00e9 de presse\u00a0\u00bb &#8212; Tafalgie Therapeutics\" data-secret=\"g39YGOytOR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/tafalgie.fr\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Tafalgie Therapeutics remporte le programme EIC Nous sommes fiers d\u2019annoncer que Tafalgie Therapeutics fait partie des quarante-sept soci\u00e9t\u00e9s europ\u00e9ennes (dont douze fran\u00e7aises) s\u00e9lectionn\u00e9es \u00e0 la suite de l\u2019appel de projets lanc\u00e9 par le Conseil Europ\u00e9en de l\u2019Innovation (the European Innovation Council, EIC) en novembre 2023 pour le programme \u00ab&nbsp;Accelerator&nbsp;\u00bb, qui r\u00e9compense des soci\u00e9t\u00e9s faisant preuve [&hellip;]","thumbnail_url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_94576008-scaled.jpeg","thumbnail_width":2560,"thumbnail_height":1703}